Advertisement.

BGLC Projected Dividend Yield

BioNexus Gene Lab Corp ( NASDAQ : BGLC )

BioNexus Gene Lab is a molecular diagnostics company focused on the application of functional genomics. Co.'s focus is on developing and marketing non-invasive blood tests for early detection of diseases. Co.'s non-invasive blood tests analyze changes in ribonucleic acid to detect the risk potentiality of various diseases. These diseases include cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate and colon), bowel diseases (colitis and Crohn) and osteoarthritis. This blood based genomic biomarker approach is based on the scientific observation that circulating blood reflects, in a detectable way, what is occurring throughout the body.

21 YEAR PERFORMANCE RESULTS

BGLC Dividend History Detail
BGLC Dividend News
BGLC Competitors News

# of Shares: 0

Closing Price: 0.46

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000